In addition, the result revealed that VDAC1 exhibited significantly higher expression levels in many types of malignant tumors such as bladder cancer (BLCA), cholangiocarcinoma (CHOL), chromophobe renal cell carcinoma (KICH), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), and stomach adenocarcinomas (STAD). The gene discussed is VDAC1; the disease is gastric adenocarcinoma.